John D. Shaughnessy

1.4k total citations
30 papers, 998 citations indexed

About

John D. Shaughnessy is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, John D. Shaughnessy has authored 30 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in John D. Shaughnessy's work include Multiple Myeloma Research and Treatments (20 papers), Glycosylation and Glycoproteins Research (4 papers) and Allergic Rhinitis and Sensitization (4 papers). John D. Shaughnessy is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Glycosylation and Glycoproteins Research (4 papers) and Allergic Rhinitis and Sensitization (4 papers). John D. Shaughnessy collaborates with scholars based in United States, Canada and Poland. John D. Shaughnessy's co-authors include Bart Barlogie, Maurizio Zangari, Guido Tricot, John Crowley, Elias Anaissie, Joth Jacobson, Fenghuang Zhan, Yiming Zhou, Leslie C. Grammer and Martha A. Shaughnessy and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

John D. Shaughnessy

30 papers receiving 975 citations

Peers

Countries citing papers authored by John D. Shaughnessy

Since Specialization

Citations

This map shows the geographic impact of John D. Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Shaughnessy more than expected).

Fields of papers citing papers by John D. Shaughnessy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Shaughnessy. The network helps show where John D. Shaughnessy may publish in the future.

Co-authorship network of co-authors of John D. Shaughnessy

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Shaughnessy. A scholar is included among the top collaborators of John D. Shaughnessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Shaughnessy. John D. Shaughnessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages 2024 ·Blood Cancer Journal ·Yan Cheng, Fumou Sun, Daisy Alapat, Visanu Wanchai, (unknown), Eric R. Siegel, Hongwei Xu, Sadie Johnson, (unknown), Clyde Bailey, Cody Ashby, Michael Bauer, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, (unknown), John D. Shaughnessy, (unknown)	13
2	Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma 2023 ·PubMed ·Samer Al Hadidi, Deepa Dongarwar, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Frits van Rhee	1
3	Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma 2022 ·JAMA Network Open ·(unknown), Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D. Shaughnessy, Fenghuang Zhan, Guido Tricot, Frits van Rhee, Samer Al Hadidi	31
4	Targeting the CD28-B7 Pro-Survival Pathway In Multiple Myeloma 2010 ·Blood ·Jayakumar R. Nair, Louise Carlson, (unknown), (unknown), (unknown), John D. Shaughnessy, P. Leif Bergsagel, Lawrence Boise, Asher Chanan‐Khan, Kelvin P. Lee	1
5	High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis 2009 ·European Journal Of Haematology ·Anne‐Tove Brenne, Unn‐Merete Fagerli, John D. Shaughnessy, Thea Kristin Våtsveen, Torstein B. Rø, Hanne Hella, Fenghuang Zhan, Bart Barlogie, Anders Sundan, Magne Børset, Anders Waage	34
6	The molecular characterization and clinical management of multiple myeloma in the post-genome era 2009 ·Leukemia ·Yiming Zhou, Bart Barlogie, John D. Shaughnessy	69
7	Immunization With a Recombinant MAGE-A3 Protein After High-dose Therapy for Myeloma 2007 ·Journal of Immunotherapy ·Susann Szmania, Sacha Gnjatic, Guido Tricot, Katie Stone, Fenghuang Zhan, Amberly Moreno, Bradley A. Thuro, Jos Melenhorst, John Barrett, John D. Shaughnessy, Lloyd J. Old, Bart Barlogie, Vincent Brichard, Frits van Rhee	32
8	Gene expression profiling and multiple myeloma 2005 ·Best Practice & Research Clinical Haematology ·John D. Shaughnessy, Fenghuang Zhan, Barthel Barlogie, A. Keith Stewart	19
9	Total Therapy 2 (TT2) for Multiple Myeloma (MM): Thalidomide (T) Effects Superior Complete Response (CR) and Event-Free Survival (EFS); Similar Overall Survival (OS) Linked to Shorter Post-Relapse Survival. 2005 ·Blood ·Guido Tricot, Erik Rasmussen, Elias Anaissie, Frits van Rhee, Maurizio Zangari, Klaus Hollmig, Lisa Jackson, Joshua Epstein, John D. Shaughnessy, John Crowley, Bart Barlogie	7
10	Results of total therapy 2 (TT 2), a phase III randomized trial, to determine the role of thalidomide (THAL) in the upfront management of multiple myeloma (MM) 2005 ·Journal of Clinical Oncology ·Bart Barlogie, Guido Tricot, John D. Shaughnessy, Erik Rasmussen, E. Anaissie, (unknown), Athanasios Fassas, Raymond Thertulien, Frits van Rhee, John Crowley	7
11	Identification of Three Novel Chromosomal Translocation Partners Involving the Immunoglobulin Loci in Newly Diagnosed Myeloma and Human Myeloma Cell Lines. 2005 ·Blood ·Ichiro Hanamura, Shinsuke Iida, Ryuzo Ueda, Michael Kuehl, (unknown), Leif Bergsagel, Jeffrey R. Sawyer, Bart Barlogie, John D. Shaughnessy	9
12	FDG PET Functional Imaging in Multiple Myeloma - Clinically Important Caveats, Pitfalls, and Pearls. 2004 ·Blood ·Ronald C. Walker, Laurie Jones-Jackson, Marisa H. Miceli, Elias Anaissie, Terri L. Alpe, Joshua Epstein, Guido Tricot, John D. Shaughnessy, Bart Barlogie	2
13	High heparanase activity in multiple myeloma is associated with elevated microvessel density. 2003 ·PubMed ·Thomas J. Kelly, Hua‐Quan Miao, Yang Yang, Elizabeth Navarro, Paul Kussie, Yan Huang, Veronica MacLeod, (unknown), Lija Joseph, Fenghuang Zhan, Maurizio Zangari, Bart Barlogie, John D. Shaughnessy, Ralph D. Sanderson	146
14	High-dose therapy and immunomodulatory drugs in multiple myeloma 2002 ·Seminars in Oncology ·Barthel Barlogie, John D. Shaughnessy, Maurizio Zangari, Guido Tricot	14
15	Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma 2001 ·British Journal of Haematology ·Jeffrey R. Sawyer, Janet L. Lukacs, Edward L. Thomas, Charles M. Swanson, (unknown), Gael Sammartino, (unknown), Nikhil C. Munshi, Guido Tricot, John D. Shaughnessy, Bart Barlogie	70
16	Genes associated with immunoglobulin V(D)J recombination are linked on mouse chromosome 2 and human chromosome 11 1993 ·Immunogenetics ·Konrad Hüppi, David Siwarski, John D. Shaughnessy, M Klemsz, Masaki Shirakata, Richard A. Maki, Hitomi Sakano	4
17	A restriction fragment length polymorphism at murineGludlocus co-segregates withRib-1,Es-10, andTcraon chromosome 14 1989 ·Nucleic Acids Research ·John D. Shaughnessy, (unknown), Robert Duncan, Marilyn Porter, Carl Banner	4
18	241 Safety and immunogenicity of immnotherapy with polymerized tree, grass and ragweed in patients with multiple inhalant sensitivities 1985 ·Journal of Allergy and Clinical Immunology ·Leslie C. Grammer, (unknown), (unknown), John D. Shaughnessy, Roy Patterson	1
19	Persistence of efficacy after a brief course of polymerized ragweed allergen: A controlled study 1984 ·Journal of Allergy and Clinical Immunology ·Leslie C. Grammer, Martha A. Shaughnessy, Irena M. Suszko, John D. Shaughnessy, Roy Patterson	42
20	Asthma as a variable in a study of immunotherapy for allergic rhinitis 1984 ·Journal of Allergy and Clinical Immunology ·Leslie C. Grammer, Martha A. Shaughnessy, John D. Shaughnessy, R Patterson	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact